AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 289: E1051-E1057, 2005. First published July 26, 2005; doi:10.1152/ajpendo.00094.2005
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/E1051    most recent
00094.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, C. D.
Right arrow Articles by Schwartz, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, C. D.
Right arrow Articles by Schwartz, M. W.

Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling

Christopher D. Morrison,1,2 Gregory J. Morton,1 Kevin D. Niswender,1,3 Richard W. Gelling,1 and Michael W. Schwartz1

1University of Washington and Harborview Medical Center, Seattle, Washington; 2Pennington Biomedical Research Center, Baton Rouge, Louisiana; and 3Vanderbilt University, Nashville, Tennessee

Submitted 2 March 2005 ; accepted in final form 22 July 2005

Phosphatidylinositol 3-OH-kinase (PI3K) and STAT3 are signal transduction molecules activated by leptin in brain areas controlling food intake. To investigate their role in leptin-mediated inhibition of hypothalamic neuropeptide Y (Npy) and agouti-related peptide (Agrp) gene expression, male Sprague-Dawley rats (n = 5/group) were either fed ad libitum or subjected to a 52-h fast. At 12-h intervals, the PI3K inhibitor LY-294002 (LY, 1 nmol) or vehicle was injected intracerebroventricularly (ICV) as a pretreatment, followed 1 h later by leptin (3 µg icv) or vehicle. Fasting increased hypothalamic Npy and Agrp mRNA levels (P < 0.05), and ICV leptin administration prevented this increase. As predicted, LY pretreatment blocked this inhibitory effect of leptin, such that Npy and Agrp levels in LY-leptin-treated animals were similar to fasted controls. By comparison, leptin-mediated activation of hypothalamic STAT3 signaling, as measured by induction of both phospho-STAT3 immunohistochemistry and suppressor of cytokine signaling-3 (Socs3) mRNA, was not significantly attenuated by ICV LY pretreatment. Because NPY/AgRP neurons project to the hypothalamic paraventricular nucleus (PVN), we next investigated whether leptin activation of PVN neurons is similarly PI3K dependent. Compared with vehicle, leptin increased the number of c-Fos positive cells within the parvocellular PVN (P = 0.001), and LY pretreatment attenuated this effect by 35% (P = 0.043). We conclude that leptin requires intact PI3K signaling both to inhibit hypothalamic Npy and Agrp gene expression and activate neurons within the PVN. In addition, these data suggest that leptin activation of STAT3 is insufficient to inhibit expression of Npy or Agrp in the absence of PI3K signaling.

suppressor of cytokine signaling-3; signal transducer and activator of transcription 3



Address for reprint requests and other correspondence: Michael Schwartz, Harborview Medical Center, Box 359757, 325 Ninth Ave., Seattle, WA 98108 (e-mail: mschwart{at}u.washington.edu)




This article has been cited by other articles:


Home page
PhysiologyHome page
H. Zheng and H.-R. Berthoud
Neural Systems Controlling the Drive to Eat: Mind Versus Metabolism
Physiology, April 1, 2008; 23(2): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
H. Shimizu, K. Inoue, and M. Mori
The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure
J. Endocrinol., April 1, 2007; 193(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. R. Kraemer and V. D. Castracane
Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin
Experimental Biology and Medicine, February 1, 2007; 232(2): 184 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
N. Akhter, B. W. Johnson, C. Crane, M. Iruthayanathan, Y.-H. Zhou, A. Kudo, and G. V. Childs
Anterior Pituitary Leptin Expression Changes in Different Reproductive States: In Vitro Stimulation by Gonadotropin-releasing Hormone
J. Histochem. Cytochem., February 1, 2007; 55(2): 151 - 166.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y.-S. Hsieh, S.-F. Yang, and D.-Y. Kuo
Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E123 - E131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.